Back to the RadioSpace™ home page


NewsDirect story topics:

Consumer, Business & General Interest

Current Events & Public Affairs

Entertainment & Sports

Health & Medicine


Positive Clinical-Trial Results Suggest that a New Treatment for Severe 'Osteoarthritis of the Knee' May Be on the Horizon

Ampio Pharmaceuticals ConsumerFeature


bocina.gif (3353 bytes)
Fully produced report in:
MP3 format
Ogg Vorbis format
QuickTime (MPEG-4/AAC) format
Windows Media Audio 9.2 format
(60 seconds)


  Bookmark and Share

-- How Will You Use This Story? --


:60 READER SCRIPT
(DOES NOT FULLY MATCH AUDIO)

"OSTEOARTHRITIS OF THE KNEE"--OR "O-A-K"--IS A PROGRESSIVE DISEASE THAT'S CHARACTERIZED OFTEN BY GRADUAL DEGRADATION AND LOSS OF CARTILAGE, IN THE KNEE-JOINT.  TODAY, PATIENTS WITH THE MOST-SEVERE FORM OF "O-A-K" HAVE FEW TREATMENT-OPTIONS--OTHER THAN "TOTAL KNEE ARTHROSCOPY".  HOWEVER, THERE MAY BE A NEW OPTION, ON THE HORIZON--ACCORDING TO "AMPIO PHARMACEUTICALS":  21-MILLION AMERICANS ARE CURRENTLY DIAGNOSED WITH "O-A-K".  AND, THE PREVALENCE IS EXPECTED TO INCREASE.  THAT'S WHY THE COMPANY IS DEVELOPING AN INJECTABLE TREATMENT THAT'S BASED ON A FILTRATE OF "F-D-A"-APPROVED "HUMAN SERUM ALBUMIN".  THE COMPANY IS PLEASED WITH THE RECENT CLINICAL-TRIAL RESULTS--WHERE OVER TWO-THOUSAND PATIENTS HAVE BEEN TREATED, WITH NO SERIOUS DRUG-RELATED COMPLICATIONS.  AND, IT WILL CONTINUE TO PROVIDE PATIENTS WHO ARE SUFFERING WITH SEVERE "O-A-K" AN OPPORTUNITY TO REDUCE THEIR PAIN, IMPROVE THEIR KNEE-FUNCTION, AND ACHIEVE A BETTER OVERALL QUALITY-OF-LIFE.  TO LEARN MORE, VISIT "AMPIO-PHARMA"-DOT-COM.


For more information regarding Consumer Radio Network programming--including a full listing of current ConsumerFeatures--click here.



Copyright 2017 North American Network, Inc.

Listings and resources:

Programming Resources

About RadioSpace

Audio Tips

Search

Free NewsDirect Subscription


Webmaster E-Mail